Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Jayakumar Rajadas

Jayakumar Rajadas

USA

Rajendra D. Badgaiyan

Rajendra D. Badgaiyan

USA

Susan Scanland

Susan Scanland

USA

John M. Baumann

John M. Baumann

USA

Harish C. Pant

Harish C. Pant

USA

A.V. Srinivasan

A.V. Srinivasan

India

Tyrone Genade

Tyrone Genade

USA

Mira Ambrus

Mira Ambrus

Spain

Parkinsons 2018

Sessions/Track

Session/Track:

On behalf of the Conference Organizing Committee, it is our heartiest welcome you to the “5th International conference on Parkinson's Disease and Movement Disorders” during October 17-18, 2018 at Baltimore, USA.

Parkinsons Disease 2018 is the leading gathering of neurologists, psychiatry, psychology researchers, and neurosurgeons with the theme of Movement Disorders across the Americas: Translating Science to Clinical Practice. Its main aim to deliver ideas for exchange of ideas and thoughts with the leading scientists which covers entire area of neurological disorder.

The live format of the conference will be accredited with CME and CPD Credits.

The objective of this session is to comprehend the inducement, Genesis and Diagnosis and prognosis including care giving of Parkinson’s disease and further hastening the revivification of Parkinson Disease.

Session on: Parkinson Disease

Parkinson's affliction is a dynamic issue of the sensory system that influences advancement. It develops gradually, at times starting with a barely distinguishable tremor in just a single hand. In any case, while a tremor may be the most surely understood indication of Parkinson's infection, the turmoil in like manner frequently causes strength or directing of advancement. In the early periods of Parkinson's disease, your face may demonstrate beside zero demeanours, or your arms may not swing when you walk. Your discourse may end up being fragile or slurred. Parkinson's disease signs compound as your condition propels after some time.

Related Conferences:  Parkinson’s Congress | Parkinson’s Conferences | Parkinson’s disease Conference | Neuroscience Conferences

World Summit on Stroke and Neurological Disorders, June 08-09, 2018 Baltimore, Canada, 8th International Conference and Exhibition on Addiction Research and Therapy, September 19-20, 2018 San Diego, USA, International Conference on Neurology and Radiology, September 21-22, 2018, Vancouver, Canada, International Conference on Brain Disorders and Dementia Care, September 21-22, 2018 Philadelphia, USA, International Conference on Sleep Disorders and Medicine, September 21-22, 2018, Philadelphia, USA, International Conference on Neuroimmunology and Neurological Disorders, September 26-27, 2018, Montreal, Canada, World Summit on Neurology and Neuroscience, September 26-27, 2018   Montreal, Canada, World Summit on Spine and Spinal Disorders, November 05-06, 2018, San Francisco, USA

Related Associations and Societies:

USA and Canada: American Academy of Neurology,  Movement Disorders Society,  Parkinson Society CanadaThe International Parkinson and Movement Disorder Society,  Canadian Movement Disorders Group,  Bachmann-Strauss Dystonia and Parkinson Foundation,  Parkinson’s Action Network (PAN)

Europe: UK Parkinsons Action Network,  European Neurological Society,  European Parkinsons Disease Association,  Danish Movement Disorder Society,  Italian Society  for the study of Parkinson Disease, Extrapyramidal Diseases and Dementia

Asia-Pacific and Middle East: Movement Disorder Society of Australia,  Parkinson’s Disease and Movement Disorders Society of India,  Austrian Parkinson’s Disease Society,  Movement Disorder Society of Japan

Session on: Epidemiology of Parkinsons Disease

Parkinsons disease is one of the well-known age related neurodegenerative disorder, second in recurrence just to Alzheimer's disease. Parkinsons disease also causes extensive injury of the motor or sensory pathways extending beyond the pigmental brain stem nuclei. Although the disease symptoms can be controlled by Levodopa but the etiology of the Parkinsons disease remains obscure. In the United States half a million of people are diagnosed as having PD and it is predicted to be triple over next 50 years. PD appears to be slightly more in men than in women usually ranging from 1.2:1 ratio upto 1.5:1. The Parkinsons disease market in US is expected to grow at a rate of 7.3% from sales of $1.1 billion in 2012 to $2.3 billion in 2022. The population with Parkinsons disease incurred medical expenses of approximately $14.4 per year in United States. In U.S. 15% of people with PD were in the nursing homes as compared to 9 % are of all residents aged 75-84.

Related Conferences: Parkinsons ConferenceNeurology Congress | Parkinsons Disease ConferenceNeurology Conference | Neurologists Conference

World Summit on Spine and Spinal Disorders, November 05-06, 2018, San Francisco, USA, World Summit on Neurology and Neuroscience, September 26-27, 2018 Montreal, Canada, International Conference on Neuroimmunology and Neurological Disorders, September 26-27, 2018, Montreal, Canada, International Conference on Sleep Disorders and Medicine, September 21-22, 2018, Philadelphia, USA, International Conference on Brain Disorders and Dementia Care, September 21-22, 2018 Philadelphia, USA,  International Conference on Neurology and Radiology, September 21-22, 2018, Vancouver, Canada, , 8th International Conference and Exhibition on Addiction Research and Therapy, September 19-20, 2018 San Diego, USA, World Summit on Stroke and Neurological Disorders, June 08-09, 2018 Baltimore, Canada

Related Associations and Societies:

USA and Canada: Parkinson’s Action Network (PAN),  American Academy of Neurology, Movement Disorders Society,  Bachmann-Strauss Dystonia and Parkinson Foundation,  Parkinson Society Canada,  The International Parkinson and Movement Disorder Society,  Canadian Movement Disorders Group

Europe: Italian Society  for the study of Parkinson Disease, Extrapyramidal Diseases and Dementia, UK Parkinsons Action Network,  Danish Movement Disorder Society,  European Neurological Society, European Parkinsons Disease Association

Asia-Pacific and Middle East: Movement Disorder Society of Japan, Movement Disorder Society of Australia, Austrian Parkinson’s Disease Society,  Parkinson’s Disease and Movement Disorders Society of India

Session on: Neurocognitive and Neuromuscular Disorders

Neurocognitive disorder is a reduction of cognitive function in one of these areas, especially when physical changes can be seen to have occurred in the cerebrum, for example, after neurological disease, brain injury or drug use. It occurs due to PD with behaviour disturbance. According to the recent projects of the United Nations between 2000 to 2050 the people over 65 years of age will exceed 1.1 billion worldwide. For estimation by 2050 Parkinson’s disease will be $285 billion in the USA.

Neuromuscular disorder is a disease that affects the peripheral nervous system which includes muscles, nerve-muscle junction, and peripheral nerves in the limbs and motor nerve cells in the spinal cord. Approximately 5600 people in the US are diagnosed with ALS each year. In US each year 750,000 people experience stroke, 11000 people suffer spinal cord injury, 500,000 people suffering from cerebral palsy, 270,000 with multiple sclerosis and 5.3 million with the after affects of a traumatic brain injury and amyotrophic lateral sclerosis.

Related ConferencesParkinsons ConferenceNeurology CongressParkinsons Disease Conference Neurology Conference | Neurologists Conference

World Summit on Neurology and Neuroscience, September 26-27, 2018 Montreal, Canada,  8th International Conference and Exhibition on Addiction Research and Therapy, September 19-20, 2018 San Diego, USA, World Summit on Spine and Spinal Disorders, November 05-06, 2018, San Francisco, USA, World Summit on Stroke and Neurological Disorders, June 08-09, 2018 Baltimore, Canada, International Conference on Neuroimmunology and Neurological Disorders, September 26-27, 2018, Montreal, Canada, International Conference on Sleep Disorders and Medicine, September 21-22, 2018, Philadelphia, USA, International Conference on Brain Disorders and Dementia Care, September 21-22, 2018 Philadelphia, USA,  International Conference on Neurology and Radiology, September 21-22, 2018, Vancouver, Canada

Related Associations and Societies:

USA and Canada: Canadian Movement Disorders Group,  Parkinson’s Action Network (PAN), The International Parkinson and Movement Disorder SocietyAmerican Academy of Neurology, Movement Disorders Society,  Bachmann-Strauss Dystonia and Parkinson Foundation,  Parkinson Society Canada

Europe: European Parkinsons Disease Association,  Italian Society  for the study of Parkinson Disease, Extrapyramidal Diseases and Dementia,  UK Parkinsons Action Network,  Danish Movement Disorder Society,  European Neurological Society

Asia-Pacific and Middle East:  Parkinson’s Disease and Movement Disorders Society of India, Movement Disorder Society of Japan,  Movement Disorder Society of Australia,  Austrian Parkinson’s Disease Society

Session on: Alzheimer's Disease & Dementia

Alzheimer's is caused by cerebrum cell demise. It is a neurological issue in which the demise of cerebrum cells causes memory misfortune and intellectual decrease. The aggregate size of the cerebrum contracts in Alzheimer's, nerve cells and associations in the tissue logically lessened, which can't be seen or tried in the living mind influenced by Alzheimer's ailment, posthumous/post-mortem examination will dependably demonstrate little incorporations in the nerve tissues, called as plaques and tangles. Plaques are found between the diminishing cells in the mind - from the development of a protein called beta (amyloid plaques). The tangles exist in the mind neurons, from a breaking down of second protein, called tau.

Around the world, with Dementia or Related issue almost 44 million individuals have endured in 2015,past outcomes demonstrated 35.66 million populace lived with dementia worldwide in year 2010, with numbers anticipated that would about twofold every twenty years, to 65.7 million out of 2030 and 115.4 million out of 2050. In 2010, fifty eight for each penny of all populace with dementia lived in nations with lower or direct livelihoods, with this extent expected to ascend to 63% till 2030 and 71% by 2050.

Related ConferencesParkinsons ConferenceNeurology CongressParkinsons Disease ConferenceNeurologists Conference Neurology Conference

International Conference on Neurology and Radiology, September 21-22, 2018, Vancouver, Canada, World Summit on Neurology and Neuroscience, September 26-27, 2018 Montreal, Canada, International Conference on Brain Disorders and Dementia Care, September 21-22, 2018 Philadelphia, USA, International Conference on Sleep Disorders and Medicine, September 21-22, 2018, Philadelphia, USA, World Summit on Stroke and Neurological Disorders, June 08-09, 2018 Baltimore, Canada, International Conference on Neuroimmunology and Neurological Disorders, September 26-27, 2018, Montreal, Canada, 8th International Conference and Exhibition on Addiction Research and Therapy, September 19-20, 2018 San Diego, USA, World Summit on Spine and Spinal Disorders, November 05-06, 2018, San Francisco, USA

Related Associations and Societies:

USA and Canada: Parkinson Society Canada, Canadian Movement Disorders Group, Bachmann-Strauss Dystonia and Parkinson Foundation, Parkinson’s Action Network (PAN),  The International Parkinson and Movement Disorder SocietyAmerican Academy of Neurology,  Movement Disorders Society

Europe: European Neurological Society, European Parkinsons Disease Association,  Danish Movement Disorder Society,  Italian Society  for the study of Parkinson Disease, Extrapyramidal Diseases and Dementia,  UK Parkinsons Action Network

Asia-Pacific and Middle East: Austrian Parkinson’s Disease Society,  Parkinson’s Disease and Movement Disorders Society of India,  Movement Disorder Society of Japan,  Movement Disorder Society of Australia

Session on: Risk Factors of Parkinsons disease

Risk factor for the Parkinsons disease mainly depends on age, hereditary, sex and exposure to toxins. Men are more affected than women; 25%-45% are caused by the loss of dopamine which causes rigid movements. Advancing age is a factor that is more consistently associated with an increase in the Parkinsons disease; only 5%-10% of people get PD before age of 40. It involve some of the symptoms like anxiety, cognitive problems, tremor or shaking, depression, trouble sleeping, low voice, loss of smell etc. Now a day’s Head injury and Gene variation is also a factor for Parkinsons disease.

Related ConferencesParkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference  | Neurologists Conference

8th International Conference and Exhibition on Addiction Research and Therapy, September 19-20, 2018 San Diego, USA, World Summit on Spine and Spinal Disorders, November 05-06, 2018, San Francisco, USA, International Conference on Neurology and Radiology, September 21-22, 2018, Vancouver, Canada, International Conference on Neuroimmunology and Neurological Disorders, September 26-27, 2018, Montreal, Canada, World Summit on Neurology and Neuroscience, September 26-27, 2018 Montreal, Canada, International Conference on Brain Disorders and Dementia Care, September 21-22, 2018 Philadelphia, USA, International Conference on Sleep Disorders and Medicine, September 21-22, 2018, Philadelphia, USA, World Summit on Stroke and Neurological Disorders, June 08-09, 2018 Baltimore, Canada

Related Associations and Societies:

USA and Canada: Movement Disorders Society,  Parkinson Society Canada,  Canadian Movement Disorders Group,  Bachmann-Strauss Dystonia and Parkinson Foundation,  Parkinson’s Action Network (PAN),  The International Parkinson and Movement Disorder SocietyAmerican Academy of Neurology

Europe: UK Parkinsons Action Network, Italian Society  for the study of Parkinson Disease, Extrapyramidal Diseases and Dementia,  European Neurological Society,  European Parkinsons Disease Association,  Danish Movement Disorder Society

Asia-Pacific and Middle East: Movement Disorder Society of Australia,  Austrian Parkinson’s Disease Society , Parkinson’s Disease and Movement Disorders Society of India,  Movement Disorder Society of Japan

Session on:  Diagnostic and Neuroimaging for Parkinsons Disease

There is no direct treatment for Parkinsons disease as well any blood test or brain scan that confirms the diagnosis. Most PD treatments aim to restore the proper of the neurotransmitter acetylcholine and dopamine by increasing the dopamine levels. Treatment is totally based on the medical history and a neurological examination. At present there is no cure for PD, medications can lessen its symptoms and later stages surgery can be done. Parkinsons in the body; magnetic resonance imaging (MRI) is a test that produces very clear image of the human body without the use of X-rays. Instead of MRI uses a large magnet, radio waves, and a computer to produce these images. Medications are in three stages- first includes the drug which is known as levodopa which increase the dopamine in the brain, the second set of drugs eases some of the Parkinsons disease symptoms and the third set of drugs helps to control the non-motor symptoms including depression.

Related ConferencesParkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference |  Neurologists Conference

World Summit on Stroke and Neurological Disorders, June 08-09, 2018 Baltimore, Canada, 8th International Conference and Exhibition on Addiction Research and Therapy, September 19-20, 2018 San Diego, USA, World Summit on Spine and Spinal Disorders, November 05-06, 2018, San Francisco, USA, International Conference on Sleep Disorders and Medicine, September 21-22, 2018, Philadelphia, USA, International Conference on Brain Disorders and Dementia Care, September 21-22, 2018 Philadelphia, USA, World Summit on Neurology and Neuroscience, September 26-27, 2018 Montreal, Canada, International Conference on Neuroimmunology and Neurological Disorders, September 26-27, 2018, Montreal, Canada, International Conference on Neurology and Radiology, September 21-22, 2018, Vancouver, Canada

Related Associations and Societies:

USA and Canada: American Academy of Neurology,  Movement Disorders Society,  The International Parkinson and Movement Disorder Society,  Parkinson Society Canada,  Canadian Movement Disorders Group,  Bachmann-Strauss Dystonia and Parkinson Foundation,  Parkinson’s Action Network (PAN)

Europe: Danish Movement Disorder Society,  UK Parkinsons Action Network,  Italian Society  for the study of Parkinson Disease, Extrapyramidal Diseases and Dementia,  European Neurological Society, European Parkinsons Disease Association

Asia-Pacific and Middle East: Movement Disorder Society of Japan,  Parkinson’s Disease and Movement Disorders Society of India,  Movement Disorder Society of Australia,  Austrian Parkinson’s Disease Society,

Session on:  Pathophysiology and pharmacology

The most prominent pathological lesion observed in PD occurs in the basal ganglia of the brain’s extra-pyramidal system. Non-PD patients and without nigrostriatal degeneration develops dyskinesias in response to dopaminergic. It is caused by gradual loss of nerve cells in the brain area called nigra and also by low and falling dopamine levels. The worldwide prevalence of Parkinson disease is anticipated to grow to 2.89 million cases worldwide by 2022.

Related ConferencesParkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference

International Conference on Neurology and Radiology, September 21-22, 2018, Vancouver, Canada, World Summit on Stroke and Neurological Disorders, June 08-09, 2018 Baltimore, Canada, International Conference on Neuroimmunology and Neurological Disorders, September 26-27, 2018, Montreal, Canada, 8th International Conference and Exhibition on Addiction Research and Therapy, September 19-20, 2018 San Diego, USA, World Summit on Spine and Spinal Disorders, November 05-06, 2018, San Francisco, USA, International Conference on Sleep Disorders and Medicine, September 21-22, 2018, Philadelphia, USA, International Conference on Brain Disorders and Dementia Care, September 21-22, 2018 Philadelphia, USA, World Summit on Neurology and Neuroscience, September 26-27, 2018 Montreal, Canada

Related Associations and Societies:

USA and Canada: Parkinson’s Action Network (PAN),  American Academy of Neurology,  Movement Disorders Society,  The International Parkinson and Movement Disorder Society,  Parkinson Society Canada, Canadian Movement Disorders Group,  Bachmann-Strauss Dystonia and Parkinson Foundation

Europe: European Neurological Society,  European Parkinsons Disease Association,  Danish Movement Disorder Society,  UK Parkinsons Action Network,  Italian Society  for the study of Parkinson Disease, Extrapyramidal Diseases and Dementia

Asia-Pacific and Middle East: Austrian Parkinson’s Disease Society,  Movement Disorder Society of Japan,  Parkinson’s Disease and Movement Disorders Society of India,  Movement Disorder Society of Australia

Session on:  Parkinsons disease: Complications

Parkinsons disease is not thought to be a life threatening condition, but rather it has a vast effect of your personal satisfaction. With time, the sickness can bring about issues with speech, movement disorder, and brain functioning. The major complication in Parkinsons disease are blood pressure changes, depression, emotional changes, thinking difficulties, fatigue, sexual dysfunction, smell dysfunction, pain and sleep disorders.

Related Conferences: Parkinsons Conference | Neurology Congress |  Parkinsons Disease Conference | Neurology Conference | Neurologists Conference

International Conference on Neurology and Radiology, September 21-22, 2018, Vancouver, Canada, World Summit on Neurology and Neuroscience, September 26-27, 2018 Montreal, Canada, World Summit on Stroke and Neurological Disorders, June 08-09, 2018 Baltimore, Canada, International Conference on Brain Disorders and Dementia Care, September 21-22, 2018 Philadelphia, USA, International Conference on Neuroimmunology and Neurological Disorders, September 26-27, 2018, Montreal, Canada, International Conference on Sleep Disorders and Medicine, September 21-22, 2018, Philadelphia, USA, 8th International Conference and Exhibition on Addiction Research and Therapy, September 19-20, 2018 San Diego, USA, World Summit on Spine and Spinal Disorders, November 05-06, 2018, San Francisco, USA

Related Associations and Societies:

USA and Canada: Bachmann-Strauss Dystonia and Parkinson Foundation,  Parkinson’s Action Network (PAN),  American Academy of Neurology,  Movement Disorders Society,  The International Parkinson and Movement Disorder Society,  Parkinson Society Canada,  Canadian Movement Disorders Group

Europe: Italian Society  for the study of Parkinson Disease, Extrapyramidal Diseases and Dementia, European Neurological Society,  European Parkinsons Disease Association,  Danish Movement Disorder Society,  UK Parkinsons Action Network

Asia-Pacific and Middle East: Movement Disorder Society of Australia,  Austrian Parkinson’s Disease Society,  Movement Disorder Society of Japan,  Parkinson’s Disease and Movement Disorders Society of India

Session on:  Managing life with Parkinsons disease

It is important to develope a solid PD management plan because PD is a chronic disease. Managing with Parkinsons disease includes building a health care team with proper doctors, proper intake of medications, exercises, nutrition and sleep.

Related ConferencesParkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference  | Neurologists Conference

World Summit on Spine and Spinal Disorders, November 05-06, 2018, San Francisco, USA, International Conference on Neurology and Radiology, September 21-22, 2018, Vancouver, Canada, 8th International Conference and Exhibition on Addiction Research and Therapy, September 19-20, 2018 San Diego, USA, World Summit on Neurology and Neuroscience, September 26-27, 2018 Montreal, Canada, International Conference on Sleep Disorders and Medicine, September 21-22, 2018, Philadelphia, USA, World Summit on Stroke and Neurological Disorders, June 08-09, 2018 Baltimore, Canada, International Conference on Neuroimmunology and Neurological Disorders, September 26-27, 2018, Montreal, Canada, International Conference on Brain Disorders and Dementia Care, September 21-22, 2018 Philadelphia, USA

Related Associations and Societies:

USA and Canada: Canadian Movement Disorders Group,  Bachmann-Strauss Dystonia and Parkinson Foundation,  Parkinson’s Action Network (PAN),  American Academy of Neurology,  Movement Disorders Society,  The International Parkinson and Movement Disorder Society,  Parkinson Society Canada

Europe: UK Parkinsons Action Network,  Italian Society  for the study of Parkinson Disease, Extrapyramidal Diseases and Dementia,  European Neurological Society,  European Parkinsons Disease Association,  Danish Movement Disorder Society

Asia-Pacific and Middle East: Parkinson’s Disease and Movement Disorders Society of India, Movement Disorder Society of Australia,  Austrian Parkinson’s Disease Society,  Movement Disorder Society of Japan

Session on:  Novel Insights and therapeutics for Parkinsons disease

Parkinsons disease is the essential growth driver of the worldwide Parkinsons disease therapeutics. Most mutations such as SNCA, PINK1, PARK2, PARK7, PLA2G6, FBXO7 and ATP13A2 are the rare cause of the disease and one particular mutation in LRRK2 has been found common in certain populations. The enzymatic function of the mitochondrial localized kinase PINK1 is thereby essential and delivers a fast production of Parkin from its uniform distribution in the cytoplasm to damaged mitochondria. The therapeutics of Parkinsons Disease includes designing a Clinical trial for Parkinson, Outcome of clinical trials in PSP, therapeutic options for mood, Cognition and Psychosis. Physical therapy cannot cure Parkinsons disease but therapy can help to compensate the changes brought about by the condition, physical therapy can help with balance problems, fatigue, pain, weakness and sometimes local heat application is produced with high frequency to relieve muscle aches and pain.

Related Conferences: Parkinsons ConferenceNeurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference

International Conference on Brain Disorders and Dementia Care, September 21-22, 2018 Philadelphia, USA, World Summit on Spine and Spinal Disorders, November 05-06, 2018, San Francisco, USA, International Conference on Neuroimmunology and Neurological Disorders, September 26-27, 2018, Montreal, Canada, International Conference on Neurology and Radiology, September 21-22, 2018, Vancouver, Canada, World Summit on Stroke and Neurological Disorders, June 08-09, 2018 Baltimore, Canada, 8th International Conference and Exhibition on Addiction Research and Therapy, September 19-20, 2018 San Diego, USA, International Conference on Sleep Disorders and Medicine, September 21-22, 2018, Philadelphia, USA, World Summit on Neurology and Neuroscience, September 26-27, 2018 Montreal, Canada

Related Associations and Societies:

USA and Canada: Parkinson Society Canada,  Canadian Movement Disorders Group,  Bachmann-Strauss Dystonia and Parkinson Foundation,  Parkinson’s Action Network (PAN),  American Academy of Neurology,  Movement Disorders Society,  The International Parkinson and Movement Disorder Society

Europe: Danish Movement Disorder Society,  UK Parkinsons Action Network,  Italian Society  for the study of Parkinson Disease, Extrapyramidal Diseases and Dementia,  European Neurological Society, European Parkinsons Disease Association

Asia-Pacific and Middle East: Movement Disorder Society of Japan,  Parkinson’s Disease and Movement Disorders Society of India,  Movement Disorder Society of Australia,  Austrian Parkinson’s Disease Society

Session on:  Neural Transplantation

Neural transplantation is the transplantation of nerve cells and tissues into the brain and spinal cord. The cell replacement for Parkinsons Disease is based on two hypothesis- firstly the early symptoms of PD are dependent on the loss of the dopaminergic neurons in the nigrostriatal pathways and secondly the dopaminergic neurons and gathered into dopamine deficient striatum can replace those neurons which has been lost during the disease process and can reverse some extent of the major symptoms of Parkinson disease.

Related Conferences: Parkinsons ConferenceNeurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference

World Summit on Neurology and Neuroscience, September 26-27, 2018 Montreal, Canada, International Conference on Brain Disorders and Dementia Care, September 21-22, 2018 Philadelphia, USA, International Conference on Sleep Disorders and Medicine, September 21-22, 2018, Philadelphia, USA, World Summit on Spine and Spinal Disorders, November 05-06, 2018, San Francisco, USA, 8th International Conference and Exhibition on Addiction Research and Therapy, September 19-20, 2018 San Diego, USA,  International Conference on Neuroimmunology and Neurological Disorders, September 26-27, 2018, Montreal, Canada, World Summit on Stroke and Neurological Disorders, June 08-09, 2018 Baltimore, Canada, International Conference on Neurology and Radiology, September 21-22, 2018, Vancouver, Canada

Related Associations and Societies:

USA and Canada: The International Parkinson and Movement Disorder Society,  Parkinson Society Canada, Canadian Movement Disorders Group,  Bachmann-Strauss Dystonia and Parkinson Foundation, Parkinson’s Action Network (PAN),  American Academy of Neurology,  Movement Disorders Society

Europe: European Parkinsons Disease Association,  Danish Movement Disorder Society,  UK Parkinsons Action Network,  Italian Society  for the study of Parkinson Disease, Extrapyramidal Diseases and Dementia,  European Neurological Society

Asia-Pacific and Middle East: Austrian Parkinson’s Disease Society,  Movement Disorder Society of Japan, Parkinson’s Disease and Movement Disorders Society of India,  Movement Disorder Society of Australia

Session on:  Paediatric Movement disorders

Paediatric movement disorder is a moderately new and developing field of child neurology. While hypokinetic scatters, for example, Parkinson disease prevails in adults. There are many genetic disease which cause secondary movement disorders in childhood. Propels in paediatric movement disorder have been made by solidifying movement disorder definitions, growing the range of clinical phenotypes, understanding genetic reasons for movement disorders, and thoroughly assessing treatment adequacy for normal movement disorders. The central nervous systems typically implicated in disorders of movement are the basal and frontal cortex. Five areas were highlighted these advances: consensus definitions, newly found PRRT2 mutation, clinical and genetic range of GLUT-1 lack and neurodegeneration with brain iron aggregation (NBIA) issue, and exhaustive behavioural interventions for tics (CBIT).

Related ConferencesParkinsons Conference | Neurology Congress | Parkinsons Disease Conference  |Neurology Conference  | Neurologists Conference

International Conference on Neurology and Radiology, September 21-22, 2018, Vancouver, Canada, World Summit on Neurology and Neuroscience, September 26-27, 2018 Montreal, Canada, World Summit on Stroke and Neurological Disorders, June 08-09, 2018 Baltimore, Canada, International Conference on Brain Disorders and Dementia Care, September 21-22, 2018 Philadelphia, USA, International Conference on Neuroimmunology and Neurological Disorders, September 26-27, 2018, Montreal, Canada, International Conference on Sleep Disorders and Medicine, September 21-22, 2018, Philadelphia, USA, 8th International Conference and Exhibition on Addiction Research and Therapy, September 19-20, 2018 San Diego, USA, World Summit on Spine and Spinal Disorders, November 05-06, 2018, San Francisco, USA

Related Associations and Societies:

USA and Canada: Movement Disorders Society,  The International Parkinson and Movement Disorder Society, Parkinson Society Canada,  Canadian Movement Disorders Group,  Bachmann-Strauss Dystonia and Parkinson Foundation,  Parkinson’s Action Network (PAN),  American Academy of Neurology

Europe: European Neurological Society,  European Parkinsons Disease Association,  Danish Movement Disorder Society,  UK Parkinsons Action Network,  Italian Society  for the study of Parkinson Disease, Extrapyramidal Diseases and Dementia

Asia-Pacific and Middle East: Movement Disorder Society of Australia,  Austrian Parkinson’s Disease Society,  Movement Disorder Society of Japan,  Parkinson’s Disease and Movement Disorders Society of India

Participation Benefits

Parkinson’s 2018 are a specially designed cluster conference which will probably unite brilliant personalities to give talks that are thought focused, and on a broad assortment of subjects associated with Parkinson’s disease and Movement Disorders, to encourage learning, inspiration and ponder – and incite discussions that matter. 

Benefits to Speakers:

·         Claim CME Credits Approved by AMA & ACCME 

·         Claim CPD Credits by CPD Standards Office, UK

·         IOCM Certificate

·         Abstracts will be published with DOI number by Cross Ref

·         Handbook & Conference kits

·         Website perceivability to more than 35K guests in less than 6 months

·         Provocative Symposia's and Workshops

·         One on One Meeting with Eminent Speakers

·         Unparalleled opportunity to give presentations and network with other key opinion leaders in the field.

·         Live Streaming of the gathering

·         Get worldwide acknowledgement to your profile and Research

·         Keynote sessions by world's most famous scientists

·         Publish your compositions in the particular supporting International Journals

·         Access to Preconference Workshops

·         Group Registration Benefits at the conference

·         Research Oriented Presentations at our Gatherings

·         Encounter world class services and friendliness at the meeting

 

Benefits to Delegates:

·         Participation Certifications

·         To sharpen their skills: Delegates can analyse new ideas and procedures to make themselves extra powerful towards their work.

·         Meet experts and influencers face-to-face

·         The opportunity in an effort to blend and mingle, shape new relationships and toughen existing ones.

·         Grow: Conference will offer a unique convergence of networking, gaining knowledge of and fun right into  a single package

·         Conference attendance inspires, rejuvenates, and energizes delegates

·         Networking and informal sharing among colleagues

·         Enjoy the alluring city environment at conference venue

·         Best Hospitality services at our conference

About Conference


Parkinson’s 2018 Organising Committee, invites all the participants from all over the world to attend the Parkinson’s 2018 conference entitled “5th International conference on Parkinson's Disease and Movement Disorders” during October 17-18, 2017 in Baltimore, USA. This gathering is predominantly will focus the most recent and energizing developments in each range of Parkinson’s research, and it will offer an exceptional opportunity for specialists from all over  the world to meet, network, and distinguish with different scientific interactions.

The live format of the conference will be accredited with CME and CPD Credits

Parkinson’s disease is a dynamic neurological disorder that influences how the individual moves, including how they talk and compose. This disease is caused by low dopamine levels. Various useful treatments, utilizing therapies (physiotherapy), surgery and medications have recognized neurological disorders and changes in the patient group. People with Parkinson’s disease also experience stiffness and they find abnormality in carrying out the movements as rapidly as before- this is known as bradykinesia.

The Parkinson’s disease market in US is expected to grow at a rate of 7.3% from sales of $1.1 billion in 2012 to $2.3 billion in 2022. Approximately 1 million adults in USA are suffering from Parkinson’s disease, from where 60,000 were diagnosed annually. An estimated of 40%-60% of PD patients mainly suffering from depression. United States is in the fourth position in considering the death of people due to Parkinson’s disease. African Americans have the highest death rate of 66.4% followed by whites of 64.6%, Hispanic with 55.4% and Asians with 50.8%. Parkinson’s disease strikes 50% more men than women. The economic burden of Parkinson’s disease on patients and their families in the U.S is about $14.4 billion.

 

Why to attend:

 Parkinson’s 2018 are the leading meeting dedicated to Neurologists and Neurosurgeons researchers with the theme “Movement Disorders across the Americas: Translating Science to Clinical Practice”.

Goal of Parkinson’s2018 is to deliver an outstanding program for exchange of ideas and authoritative views by leading scientists which covers the entire spectrum of research in Parkinson’s Disease and Movement Disorders and share the cross-cultural experiences of various treatment procedures.

We strive to make Parkinson’s 2018 a success, with your support and high quality talks from both Parkinson’s disease and Movement Disorders communities. During the conference, we assure you that you will experience world class facilities and hospitality at the conference.

Approximately 1 million adults in USA are suffering from Parkinson’s disease, from where 60,000 were diagnosed annually. An estimated of 40%-60% of PD patients mainly suffering from depression. United States is in the fourth position in considering the death of people due to Parkinson’s disease.

Target audience: Neurologists, Psychiatrists, Psychologists, Neurosurgeon, Head of the department, Director, Industries, Delegates, Clinical, Physicians, Neuroscientists, Specialists,  Community members, Lecturers and Students from Academia in the study of Parkinson disease, Professors, Researchers, Scientists, Students from Academia in the research of Neurology and Neuroscience, Nurses and Therapists.

Market Analysis

Theme: Movement Disorders Across the Americas: Translating Science to Clinical Practice

On behalf of the Conference Organizing Committee, It is our heartiest welcome you to the “5th International conference on Parkinson's Disease and Movement Disorders” during October 17-18, 2017 in Baltimore, USA.

Importance and Scope:

Parkinson’s 2018 are conducted exclusively in support to worldwide neuro researchers. We endeavour to make Parkinson’s 2018 a grand success, with the support of high eminent talks from the neuro science and Parkinson’s disease communities. During the time, you spend at this congress; we promise you that we will provide you with world class facilities and hospitality.

Parkinson’s disease is a progressive disease of the nervous system set apart by tremor, muscle rigidity, and moderate, imprecise movement, chiefly affecting aged and elderly individuals. It is connected with degeneration of the basal ganglia of the brain and deficiency of the neurotransmitter dopamine.

Parkinson’s disease is a progressive neurological disorder which is caused due to neurodegeneration. About 10 million of people are suffering from Parkinson’s disease globally. The global prevalence in 2012 was approximately 2.18 million cases in worldwide where $1.15 billion in US market. The Parkinson’s disease market in US is expected to grow at a rate of 7.3% from sales of $1.1 billion in 2012 to $2.3 billion in 2022.Treatment market value is being expected to increase from $3.6 billion in 2012 to $5.3 billion in 2022. US- has the largest Parkinson’s disease therapeutics market share of 44% by 2022 which is expanding from 32% in 2012 and this will be followed by Japan, Brazil and Germany with shares of 13%, 11% and 10%. Approximately 1 million adults in USA are suffering from Parkinson’s disease, from where 60,000 were diagnosed annually. In the United Kingdom approximately 127,000 people are suffering from PD. Male got 50% higher risk than females, however 4 to 5% of the cases the sufferer is younger than 40 years and it is known as Young-onset Parkinson’s disease.  NINDS funded about $90 million out of $135 million in NIH-supported PD research in USA. 

The worldwide Parkinson's sickness showcase is divided on the premise of medication sort and topography. As per sedate sort, the market is portioned into, advertised and pipeline drugs. The showcased drugs are additionally divided into Levodopa, Dopamine agonists, Apomorphine, Glutamate rival, Anticholinergics, COMT inhibitors and MAO-B inhibitors. Topographically, the market is sectioned crosswise over four locales to be specific North America, Europe, Asia Pacific, and LAMEA.

Medicines for development issue are relied upon to be worth $3.2 billion out of 2012 and $4.8 billion out of 2017, a CAGR of 8.3%.

For more details, please visit: http://parkinsons.conferenceseries.com/

About the city:

Baltimore is the largest city of Maryland in US State and is the 29th most populous city in the country. The public and private research has a long-standing tradition and has its own identification to play role in the future. The city is rich in architecturally significant buildings in variety of styles. Some of the famous tourists spot in Baltimore are Walters Art Gallery, American Visionary Art Museum, Fell’s Point, Johns Hopkins University, National Aquarium, Harborplace, Maryland Science Center. This conference also promises you to fill with good memories at Baltimore with its attractions.

Conference Highlights:

Parkinson’s disease

Epidemiology of Parkinson’s disease

Neurocognitive and Neuromuscular Disorders

Alzheimer's Disease & Dementia

Risk factors of Parkinson’s disease

Diagnostic and Neuroimaging for Parkinson’s disease

Pathophysiology and pharmacology

Parkinson’s disease: Complications

Managing life with Parkinson’s disease

Novel Insights and therapeutics for Parkinson’s disease

Neural Transplantation

Paediatric Movement disorders

Major Associations around the globe:

Around 25 associations of Parkinson Disease are there in USA

  • Parkinson Association of the Rockies
  • Brian Grant Foundation
  • The Michael J. Fox Foundation
  • The Foundation for Mitochondrial Medicine
  • The International Parkinson and Movement Disorder Society
  • Parkinson Alliance
  • Parkinson's Action Network (PAN)
  • Bachmann-Strauss Dystonia & Parkinson Foundation
  • Parkinson's Resource Organization
  • International Association of Parkinsonism
  • Booth Gardner Parkinson’s Care Center
  • Canadian Movement Disorders Group
  • Dallas area Parkinsonism Society
  • Indian Parkinson Foundation- The Climb
  • New Mexico Parkinson’s Disease Coalition
  • Wisconsis Parkinsons Foundation

Top universities 500 globally working in the field of Parkinson Disease

  • University of Bath
  • The University of Queensland
  • University of Bristol
  • University of Cambridge
  • The Imperial College of Science and Medicine
  • Duke University
  • University of Milan
  • Karolinska Institute
  • University of Hamburg
  • The University of Edinburgh
  • University of Munich
  • University of Rochester
  • University of Zurich
  • Leiden University
  • University of Bristol
  • University of Helsinki
  • Uppsala University
  • University of Freiburg
  • University of Frankfurt
  • University of Chicago Medicine

Top universities in USA working in the field of Parkinson Disease

  • University of California
  • University of Kansas Medical Center
  • University of South Alabama 
  • University of Florida
  • University of Miami 
  • Georgia Health Sciences University
  • Emory University
  • Northwestern University Movement Disorders Center
  • Johns Hopkins Parkinson's Disease&Movement Disorders Center
  • New York University Langone Medical Center
  • University of Rochester Medical Center
  • Duke University Medical Center
  • University of North Carolina
  • Oregon Health & Science University Parkinson Center of Oregon
  • University of Pennsylvania
  • Vanderbilt University Medical Center
  • Baylor College of Medicine

Top Universities in Baltimore

Johns Hopkins University

University of Maryland, Baltimore

Morgan State University

Loyola University Maryland

Coppin State University

Industries Associated with Parkinson Research

  • Dainippon Sumitomo Pharma
  • BioSante Pharmaceuticals
  • GlaxoSmithKline (GSK)
  • Boehringer Ingelheim

Past Conference Report

Parkinsons 2017

Parkinson-2017 Report

Past Conference Report on Parkinson-2017

Conferenceseries LLC takes a great pride in announcing the commencement of 3rd International Conference on Parkinson’s disease and Movement Disorders-2017 during September 25-26, 2017 at Chicago, USA. Parkinson-2017 has received a benevolent response from all over the world. This has been conducted with the aim and the categorical intent of promoting the developments of new perceptions and ideas for exploring the high level of knowledge reached by scientific community on Parkinson’s and Disorders. The extremely illustrious conference hosted by Conferenceseries LLC was marked with the attendance of young and brilliant researchers, business delegates, Neurologists, Neurosurgeon, Neuroscientists and talented student communities.

Parkinson 2017 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of Parkinson’s disease and Movement Disorders.

The conference was organized around the theme “Research Strategies, propelled advancements and developments in Parkinson’s disease”. The event implanted a firm relation of upcoming strategies in the field of Parkinson’s disease with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

This conference brought together Leading World Parkinson’s Neurologists, Physicians, Neuroscientists, Specialists, Researchers, Professors, Industrial Experts, Neurosurgeons, Psychiatrist, Nutritional Scientists, Lecturers and Students from Academia in the study of Parkinson disease, Students from Academia in the research of Neurology and Neuroscience, Therapists in which many issues in Parkinson’s field were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided an opportunity for an open and animated sharing of ideas and experiences.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Parkinson’s disease.

The Keynote Session by:

Susan Scanland, Dementia Connection® LLC, USA

Srinivasan Avathvadi Venkatesan, DR.M.G.R.Medical University, India

Jayakumar Rajadas, Stanford University, USA

Rajendra D Badgaiyan, University of Richmond, USA,

John M Baumann, University of Louisville, USA,

Tyrone Genade, Northwestern College, USA

Also, the poster presentations was judged by John M Baumann, University of Louisville, USA

Conferenceseries LLC offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners and Editorial Board Members of Journal of Alzheimer Disease & Parkinsonism, Journal of Neurosurgery and Journal of Neurology and Neuroscience who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

We once again thank you all for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the Clinical Research. Conferenceseries LLC therefore, is glad to announce its "5th International Conference on Parkinson’s Disease and Movement Disorders" which will be held during October 19-20, 2018 Baltimore, USA.

Mark your calendars for the upcoming extravaganza; we are hoping to see you soon at Baltimore!         

 


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date October 17-18, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Alzheimers Disease & Parkinsonism Journal of Neurosurgery Journal of Neurology and Neuroscience

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by